 Andrew Goodwin
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 10 | 2022 | 484 | 3.310 |
Why?
| | Silicon Dioxide | 7 | 2022 | 116 | 2.340 |
Why?
| | Microbubbles | 8 | 2019 | 49 | 2.160 |
Why?
| | Contrast Media | 9 | 2019 | 462 | 1.670 |
Why?
| | Prodrugs | 3 | 2022 | 49 | 1.550 |
Why?
| | Fluorocarbons | 4 | 2017 | 117 | 1.440 |
Why?
| | High-Intensity Focused Ultrasound Ablation | 3 | 2019 | 9 | 1.410 |
Why?
| | Nanostructures | 5 | 2025 | 108 | 1.400 |
Why?
| | Ultrasonography | 7 | 2017 | 750 | 1.380 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2021 | 132 | 1.310 |
Why?
| | Biosensing Techniques | 3 | 2015 | 127 | 1.270 |
Why?
| | Ultrasonic Therapy | 2 | 2018 | 15 | 1.130 |
Why?
| | Phospholipids | 2 | 2019 | 223 | 1.060 |
Why?
| | Cytosine Deaminase | 3 | 2022 | 16 | 1.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 4 | 2020 | 191 | 0.970 |
Why?
| | Antineoplastic Agents | 4 | 2025 | 2145 | 0.940 |
Why?
| | Flucytosine | 3 | 2022 | 10 | 0.900 |
Why?
| | Acoustics | 3 | 2019 | 53 | 0.870 |
Why?
| | Aptamers, Nucleotide | 3 | 2015 | 83 | 0.870 |
Why?
| | Thrombin | 3 | 2014 | 152 | 0.860 |
Why?
| | Gold | 3 | 2022 | 125 | 0.850 |
Why?
| | Phosphatidylethanolamines | 3 | 2014 | 77 | 0.830 |
Why?
| | Cross-Linking Reagents | 5 | 2024 | 212 | 0.820 |
Why?
| | Spheroids, Cellular | 4 | 2024 | 76 | 0.800 |
Why?
| | Fluorouracil | 2 | 2022 | 213 | 0.790 |
Why?
| | ErbB Receptors | 3 | 2021 | 616 | 0.770 |
Why?
| | Theranostic Nanomedicine | 2 | 2019 | 15 | 0.760 |
Why?
| | Protein Aggregates | 1 | 2021 | 72 | 0.690 |
Why?
| | Polyethylene Glycols | 4 | 2019 | 640 | 0.680 |
Why?
| | Acrylic Resins | 2 | 2018 | 46 | 0.670 |
Why?
| | DNA | 7 | 2024 | 1460 | 0.660 |
Why?
| | Drug Packaging | 1 | 2020 | 41 | 0.650 |
Why?
| | Cell Line, Tumor | 12 | 2025 | 3420 | 0.640 |
Why?
| | Embolism | 1 | 2019 | 41 | 0.630 |
Why?
| | Nitroreductases | 1 | 2019 | 5 | 0.630 |
Why?
| | Drug Delivery Systems | 4 | 2019 | 363 | 0.620 |
Why?
| | Thrombectomy | 1 | 2019 | 69 | 0.610 |
Why?
| | Hydrogels | 4 | 2025 | 675 | 0.590 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 33 | 0.590 |
Why?
| | Osmosis | 1 | 2018 | 17 | 0.590 |
Why?
| | Dendrimers | 3 | 2025 | 17 | 0.580 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 142 | 0.570 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 320 | 0.520 |
Why?
| | Neoplasms | 5 | 2024 | 2666 | 0.520 |
Why?
| | Quinones | 1 | 2015 | 9 | 0.500 |
Why?
| | Protein Kinase Inhibitors | 2 | 2019 | 920 | 0.490 |
Why?
| | Thrombosis | 1 | 2019 | 368 | 0.490 |
Why?
| | Drug Carriers | 4 | 2025 | 129 | 0.490 |
Why?
| | Nanotubes, Carbon | 3 | 2009 | 48 | 0.440 |
Why?
| | Blood Coagulation | 2 | 2013 | 254 | 0.430 |
Why?
| | Membrane Proteins | 1 | 2020 | 1167 | 0.430 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 327 | 0.430 |
Why?
| | Polyesters | 2 | 2019 | 77 | 0.410 |
Why?
| | Breast Neoplasms | 4 | 2023 | 2249 | 0.390 |
Why?
| | Molecular Imaging | 1 | 2012 | 55 | 0.380 |
Why?
| | Blood | 1 | 2012 | 106 | 0.380 |
Why?
| | Venous Thrombosis | 1 | 2013 | 187 | 0.360 |
Why?
| | Micelles | 2 | 2009 | 40 | 0.320 |
Why?
| | Adsorption | 2 | 2020 | 147 | 0.310 |
Why?
| | Photochemical Processes | 2 | 2021 | 108 | 0.310 |
Why?
| | Stress, Mechanical | 2 | 2021 | 475 | 0.300 |
Why?
| | Rabbits | 4 | 2014 | 792 | 0.300 |
Why?
| | Dextrans | 1 | 2009 | 84 | 0.300 |
Why?
| | Coated Materials, Biocompatible | 1 | 2009 | 62 | 0.290 |
Why?
| | Animals | 17 | 2025 | 37011 | 0.290 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 665 | 0.280 |
Why?
| | Metal Nanoparticles | 1 | 2009 | 88 | 0.280 |
Why?
| | Propionates | 1 | 2007 | 39 | 0.270 |
Why?
| | Drug Liberation | 2 | 2025 | 36 | 0.260 |
Why?
| | Cattle | 2 | 2019 | 982 | 0.260 |
Why?
| | Volatilization | 2 | 2017 | 56 | 0.250 |
Why?
| | Surface Properties | 2 | 2019 | 414 | 0.250 |
Why?
| | Streptavidin | 2 | 2015 | 14 | 0.250 |
Why?
| | Caco-2 Cells | 2 | 2022 | 77 | 0.240 |
Why?
| | Infrared Rays | 1 | 2005 | 25 | 0.240 |
Why?
| | Spectrometry, Fluorescence | 3 | 2021 | 172 | 0.230 |
Why?
| | Solutions | 2 | 2015 | 170 | 0.230 |
Why?
| | Particle Size | 3 | 2016 | 394 | 0.230 |
Why?
| | Nanotubes | 2 | 2018 | 47 | 0.220 |
Why?
| | Mice | 10 | 2025 | 17843 | 0.220 |
Why?
| | EGF Family of Proteins | 1 | 2022 | 16 | 0.200 |
Why?
| | Cell Adhesion | 2 | 2021 | 467 | 0.200 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2025 | 250 | 0.190 |
Why?
| | Humans | 21 | 2025 | 137514 | 0.180 |
Why?
| | Scattering, Radiation | 2 | 2011 | 101 | 0.180 |
Why?
| | Mice, Nude | 1 | 2022 | 696 | 0.170 |
Why?
| | Amyloid | 1 | 2021 | 89 | 0.170 |
Why?
| | Cell Death | 1 | 2021 | 370 | 0.160 |
Why?
| | Cell Communication | 1 | 2021 | 313 | 0.160 |
Why?
| | Ultrasonic Waves | 1 | 2019 | 6 | 0.160 |
Why?
| | Protein Denaturation | 1 | 2019 | 74 | 0.160 |
Why?
| | Glass | 1 | 2019 | 43 | 0.160 |
Why?
| | Enzymes, Immobilized | 1 | 2019 | 30 | 0.150 |
Why?
| | Permeability | 1 | 2019 | 162 | 0.150 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2019 | 177 | 0.140 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 151 | 0.140 |
Why?
| | Pressure | 1 | 2018 | 244 | 0.140 |
Why?
| | Metal-Organic Frameworks | 1 | 2017 | 3 | 0.140 |
Why?
| | DNA, Satellite | 1 | 2017 | 18 | 0.140 |
Why?
| | Photosensitizing Agents | 1 | 2017 | 34 | 0.130 |
Why?
| | Escherichia coli Proteins | 1 | 2019 | 195 | 0.130 |
Why?
| | Photochemotherapy | 1 | 2017 | 37 | 0.130 |
Why?
| | Cell Membrane | 1 | 2020 | 751 | 0.130 |
Why?
| | Doxorubicin | 3 | 2019 | 368 | 0.130 |
Why?
| | Poloxamer | 1 | 2016 | 13 | 0.130 |
Why?
| | Photons | 2 | 2007 | 68 | 0.130 |
Why?
| | Air | 1 | 2016 | 37 | 0.130 |
Why?
| | Biotinylation | 1 | 2015 | 32 | 0.130 |
Why?
| | Cell Movement | 1 | 2020 | 972 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 930 | 0.120 |
Why?
| | Ultraviolet Rays | 1 | 2018 | 389 | 0.120 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 682 | 0.120 |
Why?
| | Hot Temperature | 1 | 2018 | 409 | 0.120 |
Why?
| | Biotin | 1 | 2015 | 28 | 0.120 |
Why?
| | Ultrasonics | 1 | 2015 | 49 | 0.120 |
Why?
| | Gases | 1 | 2014 | 48 | 0.110 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 402 | 0.110 |
Why?
| | Temperature | 1 | 2017 | 680 | 0.110 |
Why?
| | Nanotechnology | 1 | 2014 | 126 | 0.100 |
Why?
| | Erythrocytes | 1 | 2018 | 693 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 544 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2020 | 2482 | 0.100 |
Why?
| | Polymers | 2 | 2007 | 495 | 0.090 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 2011 | 10 | 0.090 |
Why?
| | Female | 8 | 2025 | 73162 | 0.090 |
Why?
| | Light | 2 | 2011 | 383 | 0.090 |
Why?
| | Phenylpropionates | 1 | 2011 | 20 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 339 | 0.090 |
Why?
| | Water | 1 | 2014 | 464 | 0.090 |
Why?
| | Oligonucleotides | 1 | 2011 | 149 | 0.090 |
Why?
| | Insulin | 1 | 2021 | 2398 | 0.090 |
Why?
| | Lipids | 1 | 2014 | 664 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1695 | 0.080 |
Why?
| | Ferrosoferric Oxide | 1 | 2009 | 27 | 0.080 |
Why?
| | Base Sequence | 1 | 2013 | 2180 | 0.080 |
Why?
| | Protein Binding | 1 | 2015 | 2229 | 0.080 |
Why?
| | Naphthoquinones | 2 | 2007 | 19 | 0.080 |
Why?
| | Microvessels | 1 | 2009 | 86 | 0.080 |
Why?
| | Luminescent Measurements | 1 | 2009 | 76 | 0.070 |
Why?
| | Spectrum Analysis, Raman | 1 | 2008 | 41 | 0.070 |
Why?
| | Protein Array Analysis | 1 | 2008 | 57 | 0.070 |
Why?
| | Image Enhancement | 1 | 2009 | 194 | 0.070 |
Why?
| | Drug Stability | 1 | 2009 | 167 | 0.070 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2008 | 44 | 0.070 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2009 | 130 | 0.070 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 240 | 0.070 |
Why?
| | Pargyline | 1 | 2007 | 2 | 0.070 |
Why?
| | Hydroxy Acids | 1 | 2007 | 4 | 0.070 |
Why?
| | Carbon | 1 | 2009 | 223 | 0.070 |
Why?
| | Propylamines | 1 | 2007 | 11 | 0.070 |
Why?
| | Cyclization | 1 | 2007 | 20 | 0.070 |
Why?
| | Benzylamines | 1 | 2007 | 41 | 0.070 |
Why?
| | Signal Transduction | 1 | 2020 | 5096 | 0.070 |
Why?
| | Oxazines | 1 | 2005 | 30 | 0.060 |
Why?
| | Chitosan | 1 | 2025 | 34 | 0.060 |
Why?
| | Acetals | 1 | 2004 | 4 | 0.060 |
Why?
| | Time Factors | 1 | 2015 | 6817 | 0.060 |
Why?
| | Surface-Active Agents | 1 | 2005 | 92 | 0.060 |
Why?
| | Lysosomes | 1 | 2005 | 142 | 0.060 |
Why?
| | Deoxycytidine | 1 | 2025 | 176 | 0.050 |
Why?
| | Methotrexate | 1 | 2025 | 260 | 0.050 |
Why?
| | Biomarkers | 1 | 2015 | 4172 | 0.050 |
Why?
| | Antigen Presentation | 1 | 2005 | 216 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2024 | 227 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 240 | 0.050 |
Why?
| | Cadherins | 1 | 2023 | 205 | 0.050 |
Why?
| | Molecular Structure | 3 | 2009 | 508 | 0.050 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2021 | 153 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1501 | 0.040 |
Why?
| | Cell Survival | 2 | 2017 | 1122 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 604 | 0.040 |
Why?
| | Titanium | 1 | 2018 | 82 | 0.040 |
Why?
| | Singlet Oxygen | 1 | 2017 | 18 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2018 | 619 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 566 | 0.030 |
Why?
| | Fourier Analysis | 1 | 2011 | 41 | 0.020 |
Why?
| | Nonlinear Dynamics | 1 | 2011 | 91 | 0.020 |
Why?
| | Graphite | 1 | 2009 | 12 | 0.020 |
Why?
| | Cobalt | 1 | 2009 | 52 | 0.020 |
Why?
| | Blood Circulation Time | 1 | 2009 | 2 | 0.020 |
Why?
| | Myeloblastin | 1 | 2008 | 8 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2008 | 35 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 249 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2009 | 256 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2008 | 145 | 0.020 |
Why?
| | Mice, SCID | 1 | 2009 | 367 | 0.020 |
Why?
| | Spectrophotometry, Infrared | 1 | 2007 | 54 | 0.020 |
Why?
| | Azo Compounds | 1 | 2007 | 30 | 0.020 |
Why?
| | Materials Testing | 1 | 2009 | 357 | 0.020 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2005 | 41 | 0.010 |
Why?
| | Biocompatible Materials | 1 | 2009 | 424 | 0.010 |
Why?
| | Hydrolysis | 1 | 2005 | 191 | 0.010 |
Why?
| | Antigen-Presenting Cells | 1 | 2005 | 156 | 0.010 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2005 | 173 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2005 | 413 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 621 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2005 | 203 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2852 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2005 | 488 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2005 | 1150 | 0.010 |
Why?
| | Vaccines | 1 | 2005 | 411 | 0.010 |
Why?
| | Glutethimide | 1 | 1969 | 3 | 0.000 |
Why?
| | Pituitary-Adrenal System | 1 | 1969 | 161 | 0.000 |
Why?
| | Adrenal Glands | 1 | 1969 | 78 | 0.000 |
Why?
| | Adrenocorticotropic Hormone | 1 | 1969 | 142 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1969 | 149 | 0.000 |
Why?
| | Stress, Physiological | 1 | 1969 | 445 | 0.000 |
Why?
| | Rats | 1 | 1969 | 5676 | 0.000 |
Why?
| | Male | 1 | 1969 | 67718 | 0.000 |
Why?
|
|
Goodwin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|